Embracing Technologies & Enhancing Outcomes
Examining the hottest trends and techniques in drug development.
sponsored by Johnson Matthey
Experts from Johnson Matthey examine some of the hottest trends in drug development. With many new drugs suffering from poor solubility and bioavailability, Alan Chorlton discusses why solid state science is more important than ever before, while Paul Evans examines the innovator drugs today that will be tomorrow’s generic targets. Looking to the medicines of the future, Beatriz Dominguez and Ahir Pushpanath explain how enzyme engineering has opened up new possibilities in biocatalysis, and Kevin Hennessy looks at the growing interest in cannabinoid drug development. Finally, Nick Shackley gives his view on why outsourcing can help companies get the most from their molecules.
Enjoy our FREE content!
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Login if you already created an account
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine